Загрузка...
Glycogen Synthase Kinase-3: A Promising Therapeutic Target for Fragile X Syndrome
Recent advances in understanding the pathophysiological mechanisms contributing to fragile X syndrome (FXS) have increased optimism that drug interventions can provide significant therapeutic benefits. FXS results from inadequate expression of functional fragile X mental retardation protein (FMRP)....
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Research Foundation
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3205455/ https://ncbi.nlm.nih.gov/pubmed/22053151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnmol.2011.00035 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|